Expression of the glial glutamate transporter EAAT2 in the human CNS: an immunohistochemical study
- PMID: 9450673
- DOI: 10.1016/s0169-328x(97)00233-7
Expression of the glial glutamate transporter EAAT2 in the human CNS: an immunohistochemical study
Abstract
Glutamate transporters play an essential role in terminating the excitatory glutamatergic signal at post-synaptic receptors and in protecting neurones from excitotoxic effects, as well as replenishing the neurotransmitter supply at glutamatergic synapses. The distribution and density of glutamate transporters may be important determinants of vulnerability to glutamate-mediated injury. There is emerging evidence that glutamate transporter dysfunction may be present in motor neurone disease (MND). In this study, a monoclonal antibody, suitable for immunohistochemistry (IHC) in human post-mortem tissue, was produced to the human astrocytic glutamate transporter EAAT2 (excitatory amino acid transporter 2). Western blotting of homogenates of human cortical tissue with the EAAT2 antibody produced a discrete band at 66 kDa. Detailed IHC analysis of the expression of the EAAT2 protein in the human CNS was undertaken. EAAT2 was exclusively localised to astrocytes, with preferential expression in the caudate nucleus, nucleus basalis of Meynert, spinal ventral horn, cerebral cortex and hippocampus, but with lower levels of expression throughout many other CNS regions. Motor neurone groups vulnerable to neurodegeneration in MND appeared distinctive in being surrounded by extensive, coarse, strongly immunoreactive perisomatic glial profiles. Motor neurone groups which tend to be spared in MND, such as those present in the oculomotor nucleus, showed a lower expression of EAAT2, with fewer perisomatic profiles. The EAAT2 antibody will provide a useful tool for increasing our understanding of the role of EAAT2 in excitatory neurotransmission in health and disease states.
Similar articles
-
The expression of the glutamate re-uptake transporter excitatory amino acid transporter 1 (EAAT1) in the normal human CNS and in motor neurone disease: an immunohistochemical study.Neuroscience. 2002;109(1):27-44. doi: 10.1016/s0306-4522(01)00437-7. Neuroscience. 2002. PMID: 11784698
-
The expression of the glial glutamate transporter protein EAAT2 in motor neuron disease: an immunohistochemical study.Eur J Neurosci. 1998 Aug;10(8):2481-9. doi: 10.1046/j.1460-9568.1998.00273.x. Eur J Neurosci. 1998. PMID: 9767379
-
The 'glial' glutamate transporter, EAAT2 (Glt-1) accounts for high affinity glutamate uptake into adult rodent nerve endings.J Neurochem. 2003 Feb;84(3):522-32. doi: 10.1046/j.1471-4159.2003.01553.x. J Neurochem. 2003. PMID: 12558972
-
The family of sodium-dependent glutamate transporters: a focus on the GLT-1/EAAT2 subtype.Neurochem Int. 1998 Dec;33(6):479-91. doi: 10.1016/s0197-0186(98)00055-2. Neurochem Int. 1998. PMID: 10098717 Review.
-
Glutamate transporters, EAAT1 and EAAT2, are potentially important in the pathophysiology and treatment of schizophrenia and affective disorders.World J Psychiatry. 2018 Jun 28;8(2):51-63. doi: 10.5498/wjp.v8.i2.51. eCollection 2018 Jun 28. World J Psychiatry. 2018. PMID: 29988908 Free PMC article. Review.
Cited by
-
Down-Regulation of Excitatory Amino Acid Transporters EAAT1 and EAAT2 by the Kinases SPAK and OSR1.J Membr Biol. 2015 Dec;248(6):1107-19. doi: 10.1007/s00232-015-9826-5. Epub 2015 Aug 2. J Membr Biol. 2015. PMID: 26233565
-
Riluzole partially rescues age-associated, but not LPS-induced, loss of glutamate transporters and spatial memory.J Neuroimmune Pharmacol. 2013 Dec;8(5):1098-105. doi: 10.1007/s11481-013-9476-2. Epub 2013 May 25. J Neuroimmune Pharmacol. 2013. PMID: 23709339 Free PMC article.
-
Excitatory amino acid transporter EAAT-2 in tangle-bearing neurons in Alzheimer's disease.Brain Pathol. 2002 Oct;12(4):405-11. doi: 10.1111/j.1750-3639.2002.tb00457.x. Brain Pathol. 2002. PMID: 12408226 Free PMC article.
-
Region- and Activity-Dependent Regulation of Extracellular Glutamate.J Neurosci. 2018 Jun 6;38(23):5351-5366. doi: 10.1523/JNEUROSCI.3213-17.2018. Epub 2018 May 14. J Neurosci. 2018. PMID: 29760178 Free PMC article.
-
Glutamate receptor abnormalities in schizophrenia: implications for innovative treatments.Biomol Ther (Seoul). 2012 Jan;20(1):1-18. doi: 10.4062/biomolther.2012.20.1.001. Biomol Ther (Seoul). 2012. PMID: 24116269 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources